admin, Author at Integral Molecular

Published by

Integral Molecular Launches Target Specificity Technology to Improve Safety of Biotherapeutics

Integral Molecular announces the launch of the Membrane Proteome Array (MPA), a rapid and reliable platform for de-risking therapeutic development by profiling the target […]

Published by

Integral Molecular Sizes Up Ebola:Membrane Protein Specialist Maps Ebola’s Binding Sites to Advance Vaccine Discovery.

DUTTON 2016. GENETIC ENGINEERING NEWS VOL. 36, NO. 1. Read More […]

Published by

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

SAPPARAPU ET AL. 2016. NATURE 540, 443–447. Read More […]

Published by

Membrane Proteome Array

Screening the Membrane Proteome: A High-Throughput Platform for Identifying Membrane Protein Antibody Targets. 2016, GEN Read More […]

Published by

Integral Molecular Announces Breakthrough in Understanding the Functionality of GPCRs, the Largest Class of Drug Targets in Human Disease

Philadelphia, PA–(BUSINESS WIRE)–Integral Molecular, an industry leader in membrane protein antibody discovery, has announced a major advancement in understanding the functionality of G protein-coupled […]

Published by

Reporter Virus Particles

Dengue Reporter Virus Stability Read More […]

Published by

Integral Molecular Develops B-Cell Cloning Technology to Discover Rare Antibodies against Membrane Proteins

Integral Molecular, a leader in antibody discovery, announces the development of an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions […]

Published by

DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops

VAN DER WONING ET AL. 2016. MABS 8(6):1126–1135. Read More […]

Published by

Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response

GODOY-LOZANO ET AL. 2016. GENOME MED 8(1):23. Read More […]

Author: admin

Integral Molecular Launches Target Specificity Technology to Improve Safety of Biotherapeutics

Integral Molecular Sizes Up Ebola:Membrane Protein Specialist Maps Ebola’s Binding Sites to Advance Vaccine Discovery.

Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice

Membrane Proteome Array

Integral Molecular Announces Breakthrough in Understanding the Functionality of GPCRs, the Largest Class of Drug Targets in Human Disease

Reporter Virus Particles

Integral Molecular Develops B-Cell Cloning Technology to Discover Rare Antibodies against Membrane Proteins

DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops

Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response

Quick Links

Solutions

Contact Us